News

Researchers are beginning to wonder whether blockbuster drugs such as Wegovy, Ozempic and Zepbound could play a role in ...
Novo Nordisk will sell a less expensive one-month supply of Wegovy for patients who previously took compounded versions of ...
Unless you are from another planet, you’ve heard all about the new weight loss medications taking the world by storm. These ...
Dr. Rubinstein has years of experience working with patients to help them achieve their desired goals in a realistic, ...
Researchers found GLP-1s may modestly reduce the risk of 14 obesity-related cancers, especially colorectal cancer, when compared to a weight-neutral medication used to treat diabetes.
Inadequate supply has created opportunities for bad actors seeking to profit from shortages, high costs and demand ...